Transforming growth factor α protects against Fas-mediated liver apoptosis in mice
✍ Scribed by Daisuke Kanda; Hitoshi Takagi; Mitsuo Toyoda; Norio Horiguchi; Hiroaki Nakajima; Toshiyuki Otsuka; Masatomo Mori
- Book ID
- 117104172
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 329 KB
- Volume
- 519
- Category
- Article
- ISSN
- 0014-5793
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Cyclooxygenase -2 (COX-2) is upregulated in many cancers, and the prostanoids synthesized increase proliferation, improve angiogenesis, and inhibit apoptosis in several tissues. To explore the function of COX-2 in liver, transgenic (Tg) mice were generated containing a fusion gene (LIVhCOX-2) c
Transforming growth factor-a (TGFa), a member of the epidermal growth factor receptor ligand family, has been implicated in the regeneration and transformation of liver. Our recent development of mice that are homozygous for a disrupted TGFagene allowed us to assess the requirement for this growth f
In previous work we showed that interferon alfa-2b (IFN-alpha2b) increases apoptosis on rat hepatic preneoplastic foci. The aim of this study was to determine if transforming growth factor beta1 (TGF-beta1) was involved in the programmed cell death on the foci. Animals were divided into 6 groups: su
Fas-mediated apoptosis is one of the major death processes of hepatocytes in liver diseases. Although compensatory regeneration occurs during liver injury, it has not been determined whether regenerating hepatocytes die by the same apoptotic process as quiescent hepatocytes. To clarify this issue, t